Literature DB >> 33895890

Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?

Fatih Levent1,2, Oktay Senoz3, Sadık Volkan Emren4, Zeynep Yapan Emren3, Rahman Bilal Gediz5.   

Abstract

BACKGROUND: Coronary artery tortuosity (CAT) is a relatively common finding on coronary angiography and may be associated with impaired left ventricular relaxation and coronary ischemia However, the significance of CAT remains unknown. This study aimed to investigate whether the severity of tortuosity in the targeted coronary segment is a predictor of stent restenosis.
METHODS: The study included a total of 637 patients undergoing drug-eluting stent implantation due to stable or unstable angina and who had no native coronary artery stenosis on their last coronary angiogram. The patients were separated into two groups: 312 patients with in-stent restenosis and 325 patients without in-stent restenosis. All patients underwent computed tomography (CT) coronary angiography after invasive angiography and CAT was calculated using the computer software.
RESULTS: Patients with in-stent restenosis had higher CAT than those without restenosis (1.25 ± 0.11 vs. 1.11 + 0.07, p < 0.001). Multivariate Cox regression analysis showed that the tortuosity index (hazard ratio [HR]: 1.246 95% confidence interval [CI]: 1.127-1.376 p < 0.001) and the circumflex lesion (HR: 1.437 95% CI: 1.062-1.942 p = 0.019) were independently associated with in-stent restenosis. With the threshold value of severe tortuosity set at 1.15, the prediction of could be made with 81% sensitivity and 80% specificity.
CONCLUSION: The severity of tortuosity is proportional to coronary in-stent stenosis in patients with stable and unstable angina pectoris undergoing drug-eluting stent implantation for a severe single coronary artery.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Angina, unstable; Coronary angiography; Coronary artery disease; Coronary restenosis; Drug-eluting stents

Mesh:

Year:  2021        PMID: 33895890     DOI: 10.1007/s00059-021-05036-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  5 in total

1.  Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis.

Authors:  Kenichi Fujii; Gary S Mintz; Yoshio Kobayashi; Stéphane G Carlier; Hideo Takebayashi; Takenori Yasuda; Issam Moussa; George Dangas; Roxana Mehran; Alexandra J Lansky; Arlene Reyes; Edward Kreps; Michael Collins; Antonio Colombo; Gregg W Stone; Paul S Teirstein; Martin B Leon; Jeffrey W Moses
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

Review 2.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  Catheter Cardiovasc Interv       Date:  2012-02-15       Impact factor: 2.692

Review 3.  In-stent restenosis in the drug-eluting stent era.

Authors:  George D Dangas; Bimmer E Claessen; Adriano Caixeta; Elias A Sanidas; Gary S Mintz; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

4.  The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.

Authors:  S Humphries; C Bauters; A Meirhaeghe; L Luong; M Bertrand; P Amouyel
Journal:  Eur Heart J       Date:  2002-05       Impact factor: 29.983

Review 5.  Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

Authors:  H Ostermann; J van de Loo
Journal:  Haemostasis       Date:  1986
  5 in total
  1 in total

1.  Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis.

Authors:  Haokun Wu; Tianhao Yu; Ting Fan; Wenjun Liao
Journal:  Comput Math Methods Med       Date:  2022-09-19       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.